Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

MET-233I

A Study of MET233 in Individuals With Obesity or Overweight

Pfizer · Phase 1 · Completed · Enrollment 144

NCT07022977

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
(Part A) MET233n/rn/rn/rn/rn/r
(Part A) Placebon/rn/rn/rn/rn/r
(Part B) MET233n/rn/rn/rn/rn/r
(Part B) Placebon/rn/rn/rn/rn/r
(Part C) MET233n/rn/rn/rn/rn/r
(Part C) Placebon/rn/rn/rn/rn/r
(Part D) MET233n/rn/rn/rn/rn/r
(Part D) Placebon/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.